ProShares UltraPro Short QQQ, NIKE, Chevron, PepsiCo, Bristol Myers Squibb, Pfizer, and Verizon Communications are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders, usually as cash payments and sometimes as additional shares. Investors may seek them for income as well as potential price growth, but dividends aren’t guaranteed and can be reduced or stopped. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
SQQQ traded up $2.02 on Tuesday, hitting $47.92. The company had a trading volume of 58,623,761 shares, compared to its average volume of 56,072,156. The business's fifty day simple moving average is $37.99 and its 200 day simple moving average is $49.03. ProShares UltraPro Short QQQ has a 12-month low of $31.42 and a 12-month high of $90.71.
Read Our Latest Research Report on SQQQ
NIKE (NKE)
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks.
Shares of NKE stock traded down $2.45 during trading hours on Tuesday, reaching $35.81. 43,875,006 shares of the stock were exchanged, compared to its average volume of 24,575,639. NIKE has a 12-month low of $31.97 and a 12-month high of $69.14. The company has a current ratio of 2.07, a quick ratio of 1.39 and a debt-to-equity ratio of 0.39. The company's 50-day moving average price is $36.88 and its 200-day moving average price is $44.85. The firm has a market capitalization of $53.19 billion, a price-to-earnings ratio of 17.28, a price-to-earnings-growth ratio of 4.33 and a beta of 1.01.
Read Our Latest Research Report on NKE
Chevron (CVX)
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.
NYSE:CVX traded down $1.75 during mid-day trading on Tuesday, hitting $215.39. 3,324,319 shares of the stock traded hands, compared to its average volume of 10,179,243. The company has a quick ratio of 1.07, a current ratio of 1.34 and a debt-to-equity ratio of 0.16. Chevron has a 52 week low of $146.49 and a 52 week high of $236.48. The stock has a market capitalization of $423.34 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 0.50 and a beta of 0.47. The firm's 50 day moving average is $215.66 and its two-hundred day moving average is $195.82.
Read Our Latest Research Report on CVX
PepsiCo (PEP)
PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region.
NASDAQ PEP traded down $4.65 during trading on Tuesday, hitting $141.78. The stock had a trading volume of 4,213,183 shares, compared to its average volume of 8,270,772. PepsiCo has a one year low of $123.47 and a one year high of $171.48. The stock has a 50 day simple moving average of $133.81 and a 200 day simple moving average of $145.67. The stock has a market capitalization of $193.21 billion, a price-to-earnings ratio of 17.86, a P/E/G ratio of 4.23 and a beta of 0.31. The company has a debt-to-equity ratio of 1.90, a quick ratio of 0.76 and a current ratio of 0.94.
Read Our Latest Research Report on PEP
Bristol Myers Squibb (BMY)
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia.
Shares of BMY traded down $2.25 during mid-day trading on Tuesday, reaching $60.68. 8,755,695 shares of the company's stock traded hands, compared to its average volume of 11,902,429. The stock's 50-day moving average is $61.82 and its two-hundred day moving average is $60.35. The stock has a market cap of $124.04 billion, a P/E ratio of 13.48, a P/E/G ratio of 0.32 and a beta of 0.20. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.59 and a quick ratio of 1.44. Bristol Myers Squibb has a 12 month low of $45.26 and a 12 month high of $68.64.
Read Our Latest Research Report on BMY
Pfizer (PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.
Shares of NYSE:PFE traded down $0.48 on Tuesday, hitting $28.38. 16,358,869 shares of the company's stock were exchanged, compared to its average volume of 39,626,438. The stock has a market capitalization of $161.76 billion, a price-to-earnings ratio of 40.52, a price-to-earnings-growth ratio of 1.89 and a beta of 0.31. Pfizer has a 12 month low of $23.62 and a 12 month high of $31.44. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.42 and a quick ratio of 1.10. The business's 50 day simple moving average is $28.81 and its two-hundred day simple moving average is $27.00.
Read Our Latest Research Report on PFE
Verizon Communications (VZ)
Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business).
Shares of NYSE VZ traded down $0.21 during trading hours on Tuesday, reaching $46.13. The stock had a trading volume of 9,950,860 shares, compared to its average volume of 27,063,225. The company has a current ratio of 0.63, a quick ratio of 0.58 and a debt-to-equity ratio of 1.33. The firm has a market cap of $191.21 billion, a price-to-earnings ratio of 11.77, a P/E/G ratio of 1.89 and a beta of 0.28. The business's fifty day moving average price is $46.16 and its two-hundred day moving average price is $47.10. Verizon Communications has a 52-week low of $38.68 and a 52-week high of $51.68.
Read Our Latest Research Report on VZ
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.